CNIPA Fully Invalidates ASK Chemicals’ Core Foundry Material Patent
Successful full invalidation of all 40 patent claims by T&C removes technical barriers and sets a strong precedent for IP validity disputes
Successful full invalidation of all 40 patent claims by T&C removes technical barriers and sets a strong precedent for IP validity disputes
Landmark judgment clarifies creativity criteria for agrochemical compound formulations as T&C defends client’s patent in full victory against invalidation challenge
T&C secures full validity of high-speed wire cooling device patent, defeating all invalidation grounds in complex mechanical patent confirmation case
On May 15, a delegation from the Beijing Intellectual Property Protection Center (BJIPPC), led by Deputy Director Ye Gao, paid a formal site visit to T&C. The targeted inspection was arranged for select IP service providers with solid operational...
Caihe Law Firm recently achieved a favorable judgment for its client, Hangzhou-based Medical Technology Co., Ltd., in a patent invalidation administrative dispute before the Beijing Intellectual Property Court. The court ruled to revoke the rejection...
We are pleased to announce that our firm recently hosted a delegation from Lavoix, a leading European patent firm with offices in Paris and Munich, for an in-depth exchange on the latest developments in European patent law and practice.
Recently, the Guangzhou Intellectual Property Court issued Civil Ruling (2025) Yue 73 Zhi Min Chu No. 1384 in a patent infringement dispute involving dental medical devices. The case was filed by a Guangzhou-based medical technology company ...
Recently, the Beijing Intellectual Property Court issued a final judgment in an administrative dispute concerning the invalidation of an invention patent. The case involved Plaintiff (a spectral data technology company), the Defendant ...
Caihe Law Firm recently secured a significant victory before the Beijing Intellectual Property Court in a highly contested patent invalidation administrative dispute (Case No. (2025) 京73行初8677号). The Court issued a first-instance judgment...
The National Medical Products Administration (NMPA) of China has officially approved the New Drug Application (NDA) for Ecnoglutide Injection (Brand Name: Xianyida®), developed by Sciwind Biosciences Co., Ltd. ("Sciwind")...